Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 6B1 (COX6B1) is a nuclear-encoded structural subunit of the cytochrome c oxidase complex (Complex IV), the last enzyme in the mitochondrial electron transport chain responsible for the reduction of oxygen to water, driving oxidative phosphorylation and ATP production[1][3][4]. COX6B1 is primarily involved in stabilization and assembly of the cytochrome c oxidase supercomplexes, facilitating efficient electron transfer and energy production, and regulating reactive oxygen species generation[2]. Mutations in COX6B1 are associated with severe infantile encephalomyopathy and mitochondrial complex IV deficiency, indicating its crucial role in cellular respiration and mitochondrial function[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 6B1 (COX6B1).